Skip to main content

Table 4 Summary of clinicopathological data of 55 ovarian cancer patients in tissue microarray

From: Hypermethylation of the TGF-β target, ABCA1 is associated with poor prognosis in ovarian cancer patients

 

Ovarian cancer ( n  = 55)

Age at diagnosis (years)

 

  Median

51

  Range

18–81

Stage

 

  FIGO (I–II)

22

  FIGO (III–VI)

33

Grade

 

  I

9

  II

14

  III

32

Pathological type

 

  Clear cell

4

  Serous

37

  Mucinous

11

  Endometroid

3

Median survival (months)

 

  PFS

25.3

  OS

36.7

  1. PFS progression-free survival, OS overall survival.
Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us